Copyright
©The Author(s) 2023.
World J Diabetes. Sep 15, 2023; 14(9): 1369-1384
Published online Sep 15, 2023. doi: 10.4239/wjd.v14.i9.1369
Published online Sep 15, 2023. doi: 10.4239/wjd.v14.i9.1369
Table 1 Primer sequences
| Gene | Forward (5’→3’) | Reverse (5’→3’) |
| XB130 | AAGCAGCAGCTCTGATGAGG | GGTCTGGAAGGCTCTTCTGA |
| β-Actin | GGCTGTATTCCCCTCCATCG | CCAGTTGGTAACAATGCCATGT |
Table 2 Antibodies used in this study
| Gene | Brand | Provenance |
| XB130 | Abcam | Rabbit |
| Cleaved-caspase-3 | Abcam | Rabbit |
| Bcl2 | Abcam | Rabbit |
| Bax | Abcam | Rabbit |
| Ki67 | Abcam | Rabbit |
| PCNA | Abcam | Rabbit |
| AKT | Abcam | Rabbit |
| p-AKT | Abcam | Rabbit |
| p85α | Abcam | Rabbit |
| p-p85α | Abcam | Rabbit |
| β-Actin | Sigma | Mouse |
- Citation: Zhu XL, Hu DY, Zeng ZX, Jiang WW, Chen TY, Chen TC, Liao WQ, Lei WZ, Fang WJ, Pan WH. XB130 inhibits healing of diabetic skin ulcers through the PI3K/Akt signalling pathway. World J Diabetes 2023; 14(9): 1369-1384
- URL: https://www.wjgnet.com/1948-9358/full/v14/i9/1369.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i9.1369
